Canine Distemper-Adenovirus Type 2-Parvovirus Vaccine, Modified Live Virus, Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract
182 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
182
Total Reports
25
Deaths Reported
1370.0%
Death Rate
Active Ingredients
Canine Distemper-Adenovirus Type 2-Parvovirus Vaccine, Modified Live Virus, Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract
Administration Routes
SubcutaneousParenteralUnknown
Species Affected
Dog 182
Most Affected Breeds
Retriever - Labrador 25
Retriever - Golden 12
Shepherd Dog - Australian 10
Shepherd Dog - German 10
Boxer (German Boxer) 9
Terrier - Yorkshire 7
Schnauzer - Miniature 6
Dachshund - Miniature 5
Shih Tzu 5
Bulldog - French 5
Most Reported Reactions
Vomiting 47
Lethargy (see also Central nervous system depression in 'Neurological') 24
Diarrhoea 23
Lack of efficacy (virus) - parvovirus (including feline panleukopenia) 21
Facial swelling (see also 'Skin') 18
Other abnormal test result NOS 17
Pale mucous membrane 17
Lethargy (see also Central nervous system depression in Neurological) 15
Not eating 14
Death 12
Lack of efficacy - NOS 11
Death by euthanasia 10
Outcome Breakdown
Recovered/Normal
67 (36.8%)
Outcome Unknown
60 (33.0%)
Ongoing
28 (15.4%)
Died
15 (8.2%)
Euthanized
10 (5.5%)
Recovered with Sequela
2 (1.1%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.